Johanna Mercier - 10 Mar 2025 Form 4 Insider Report for GILEAD SCIENCES, INC. (GILD)

Role
Chief Commercial Officer
Signature
/s/ Edward S. Son by Power of Attorney for Johanna Mercier
Issuer symbol
GILD
Transactions as of
10 Mar 2025
Net transactions value
-$457,939
Form type
4
Filing time
12 Mar 2025, 19:15:58 UTC
Previous filing
06 Feb 2025
Next filing
22 May 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GILD Common Stock Options Exercise +8,080 +6.7% 128,059 10 Mar 2025 Direct F1
transaction GILD Common Stock Tax liability $457,939 -3,907 -3.1% $117.21 124,152 10 Mar 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GILD Restricted Stock Unit Options Exercise -8,080 -22% 28,113 10 Mar 2025 Common Stock 8,080 Direct F1, F2
transaction GILD Non-qualified Stock Option (Right to Buy) Award $0 +49,020 $0.000000 49,020 10 Mar 2025 Common Stock 49,020 $117.21 Direct F3
transaction GILD Restricted Stock Unit Award +11,090 +39% 39,203 10 Mar 2025 Common Stock 11,090 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
F2 The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.
F3 The options have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.